ArticleJournal of medical virology2026
Torque Teno Virus in Bronchoalveolar Lavage Fluid of Hematological Patients and Association With Pathogens.
Article in Journal of medical virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Torque Teno Virus Dynamics in Plasma and BAL of COVID-19 ARDS Patients With and Without ECMO.Journal of medical virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Torque teno virus (TTV) replication is tightly modulated by the host immune response. As such, TTV viremia has been investigated as a biomarker of immune competence for monitoring the risks of allograft rejection and opportunistic infections in solid organ transplant recipients. We aimed to investigate the associations between TTV levels in bronchoalveolar lavage fluid samples (BALF) and pathogen detection in patients with hematological diseases with suspicion of lower respiratory tract infection (LRTI). TTV DNA was quantified in BALF using qPCR. Linear and logistic regressions were used to study associations between TTV levels in BALF and patients' characteristics, cytological patterns and pathogen detection. A total of 330 BALF from 272 patients with hematological malignancies were included. TTV DNA was detected in 44.5% of samples. The median TTV viral load (VL) in positive samples was 6.24 log copies/mL (IQR: 4.68-7.66). Strong positive associations were found between TTV levels in BALF and a diagnosis of lymphoma, a neutrophil fraction > 3% of BALF cells, and the detection of at least one respiratory virus. To a lesser extent, allogeneic hematopoietic stem cell transplantation, significant bacterial growth in BALF culture, and cytomegalovirus detection in BALF were also associated with TTV levels. We identified in this study multiple associations with TTV VL in BALF. These findings suggest that high TTV levels in BALF could reflect an impaired local immune status, and correlate with the risk of viral LRTI in immunocompromised patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.